ELVN
Enliven TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ELVN vs peer average
22/100
ELVN vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 4 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CMPX is the first available peer comparator.
Used mainly as a small-cap oncology biotech sentiment and funding-risk comp rather than a mechanism-matched peer; similar size keeps it relevant for clinical-readout sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ELVN
Enliven Therapeutics
CMPX
Compass Therapeutics
Grade
F
C
Momentum
89
35
Value
41
41
Sentiment
28
66
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs CMPX
ELVN / CMPX
Grade Position
Below peers
ELVN vs. peer average (F vs. C)
22/100
Momentum
89
ELVNValue
41
ELVNSentiment
28
CMPXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ELVN
CMPX is the first peer returned for this comparison set.